Did a ban on diesel-fuel reduce emergency respiratory admissions for children?

Abbas El-Zein1, Iman Nuwayhid, Mutasem El-Fadel

  • 1School of Civil Engineering, University of Sydney, Sydney, Australia. aelzein@usyd.edu.au

Insights

A diesel vehicle ban in Beirut initially reduced child respiratory admissions, particularly upper respiratory infections. However, the positive impact on respiratory health was not sustained into the second year post-ban.

Area of Science:

  • Environmental Health
  • Pediatric Respiratory Medicine
  • Public Policy Impact Assessment

Background:

  • Air pollution from diesel vehicles is a significant global health concern, especially for children.
  • Lebanon lacks systematic air quality monitoring, hindering the assessment of pollution-related health impacts.
  • Beirut implemented a ban on diesel-powered motor vehicles to mitigate air pollution.

Purpose of the Study:

  • To evaluate the effect of a diesel vehicle ban in Lebanon on emergency respiratory admissions in children (<17 years).
  • To determine if the ban led to a reduction in specific respiratory conditions like asthma and pneumonia.

Main Methods:

  • Comparison of monthly respiratory admissions (total, asthma, bronchitis, pneumonia, URTI) from October to February, pre- and post-ban.
  • Utilized Poisson regression models, adjusting for meteorological factors (rainfall, humidity, temperature).
  • Analyses were conducted for 1-year and 2-year periods, with and without flu months (January, February).

Main Results:

  • A significant decrease in total respiratory admissions and upper respiratory tract infections (URTI) was observed in the first year post-ban (p < 0.05 and p < 0.001, respectively).
  • Excluding flu months, significant reductions were noted for all categories except pneumonia in the first year (p < 0.001).
  • The ban's effect diminished in the second year, with non-significant reductions for asthma and URTI when comparing 2-year pre- and post-ban periods (p < 0.1).

Conclusions:

  • The diesel vehicle ban showed a positive, albeit temporary, impact on pediatric respiratory admissions in Beirut, primarily during the first year.
  • The study highlights the need for comprehensive air quality monitoring to validate health intervention outcomes.
  • Further research is required to understand long-term effects and the specific impact on different respiratory conditions.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...